Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis licenses hepatitis B program to GSK

– GSK exercises option to license program following positive Phase 2 results – Transaction provides Ionis with significant participation in the commercial success of HBV program CARLSBAD, Calif. , Aug. 27, 2019 /PRNewswire/ —  Ionis Pharmaceuticals, Inc.